Inventiva IVA
NASDAQ IVA
$3.77 +0.48 (+14.44%)
As of: Sep 30, 2026 · 12:03 PM EDT

Inventiva (IVA) Convertible Debt (2022 - 2026)

Updated

Inventiva (IVA) reported Convertible Debt of $790,406 for Q2 2026, down 21.6% from $1.01 million a year earlier.

Analysis

Inventiva (IVA) Convertible Debt (2022 - 2026) Analysis & Trends

At the end of FY2025, Inventiva posted Convertible Debt of $878,853, down 53.3% from FY2024.

  • Convertible Debt has a three-year compound annual growth rate of -11.3% (FY2022 to FY2025).
  • By year, Convertible Debt came in at $1.88 million in FY2024 (+12.2%), $1.68 million in FY2023 (+33.2%) and $1.26 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Convertible Debt in data going back to Q4 2022.
  • Year over year, Convertible Debt gained in 1 of the last four quarters, with an average decline of 25.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Inventiva 682.13 Mn 682.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 790,406.06
Dec 31, 2025 878,852.85
Jun 30, 2025 1.01 Mn
Dec 31, 2024 1.88 Mn
Jun 30, 2024 1.67 Mn
Dec 31, 2023 1.68 Mn
Jun 30, 2023 1.48 Mn
Dec 31, 2022 1.26 Mn
API Access

Inventiva Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=IVA&period=max&api_key=YOUR_API_KEY